Radical Findings in the Mountains

When physicians examined members of a Swiss expedition to Mount Everest in the 1980s, they discovered widespread damage to the climbers' muscles. Mito-chondrial volume had decreased by 20% and there was evidence of cell deterioration in tissue samples. However, their guides, the indigenous Tibetan Sherpas, were not affected.Now a Swiss-Italian team has found that several antioxidant enzymes seem to shield the Tibetans from the insults of oxygen deficiency at high altitudes.1 "Hypoxia leads to th

Written bySilvia Sanides
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

When physicians examined members of a Swiss expedition to Mount Everest in the 1980s, they discovered widespread damage to the climbers' muscles. Mito-chondrial volume had decreased by 20% and there was evidence of cell deterioration in tissue samples. However, their guides, the indigenous Tibetan Sherpas, were not affected.

Now a Swiss-Italian team has found that several antioxidant enzymes seem to shield the Tibetans from the insults of oxygen deficiency at high altitudes.1 "Hypoxia leads to the formation of free radicals, which attack mitochondria. Neutralizing these reactive molecules protects tissue," explains Cecilia Gelfi of the Institute of Molecular Bioimaging and Physiology in Milan. She found that one enzyme, glutathione-S-transferase (GST), is elevated by 380% in the muscle of Tibetans born and raised at altitudes over 3,500 meters.

To tease apart the genetic and environmental influences, the researchers also measured the enzymatic levels in Tibetans whose parents had emigrated to the lowlands. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies